Retinal Degeneration 3 (RD3) Peptid
Kurzübersicht für Retinal Degeneration 3 (RD3) Peptid (ABIN938889)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- GQMREAERQQ RERSNAVRKV CTGVDYSWLA STPRSTYDLS PIERLQLEDV
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of RD3 antibody,
Alternative Names: RD3 control peptide, RD3 antibody Blocking Peptide, Anti-RD3 Blocking Peptide, Retinal Degeneration 3 Blocking Peptide, C1orf36 Blocking Peptide, LCA12 Blocking Peptide, RD3, RD-3, RD 3, RD-3 Blocking Peptide, RD 3 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- RD3 (Retinal Degeneration 3 (RD3))
-
Hintergrund
- RD3 is preferentially expressed in retina.Defects in RD3 are the cause of Leber congenital amaurosis type 12 (LCA12).
-
Molekulargewicht
- 23 kDa
Target
-